Effik Group

Founded in 1992, Effik is a pharmaceutical group with a strong growth rate.

Effik has developed a full range of products, in Gynaecology: contraception, vitamins and minerals for pregnancy, HRT, gynecological mycosis, acne.


Objectives

  • To be the reference gynaecology group in Europe,

  • To develop innovative products in gynaecology



    • Our branches
     
    Effik S.A., France (1992)
    Laboratorios Effik, Espagne (1994)
    Effik Italia S.p.A., Italie (2001)
    Laboratorios EFFIK, Portugal (2005)
    Effik S.A., Suisse (2006)
     
    Effik Group, the reference in Gynaecology

    In all countries where Effik is present, Effik is among the leaders in Gynaecology.

    Each year in Effik countries :

  • 3 millions of Effik scripts

  • 300.000 women on Effik contraceptives

  • 2 millions Effik anti-mycotic treatments


    • Sources: GERS, DOREMA 2007

    Effik Group : R & D activity

    Effik has concentrated its efforts on natural hormones for hormonal replacement and premature delivery prevention.

    Effik has several patents, in Europe, US and Canada.

    In 2006, Effik has launched a research program on antiandrogenic properties of a synthetic progestin.

    In 2007, Effik started an R & D program on Strepto B in pregnancy and another one in the prevention of premature delivery in twin pregnancies


    Effik Group and its partners

    Effik has licensing agreements with several pharmaceutical groups : J&J, Pfizer, Recordati, Fournier, Italfarmaco, Liconsa, Stragen, Helm …

    Alliance partnerships have been also signed with Schering Plough, Biogaran, Liconsa, Novalab, 7 Med Industrie,...


    Effik Group in exports

    Effik group exports products to South America, Asia, Eastern Europe and Africa.